Top Pharmaceuticals companies in United States by Gross Profit

This ranking features the top 669 Pharmaceuticals companies in United States ranked by Gross Profit, totalling a Gross Profit of USD 959.82 B, for January 15, 2025.

United States

Pharmaceuticals

#	Name	Gross Profit	Reported Date	Stock Price	Change	Country
1	Humana Inc. 1 HUM	USD 101.65 B	Sept. 30, 2024	USD 282.63	-1.65%	United States
2	UnitedHealth Group Incorporated 2 UNH	USD 86.91 B	Sept. 30, 2024	USD 543.74	0.48%	United States
3	Johnson & Johnson 3 JNJ	USD 60.55 B	Sept. 29, 2024	USD 144.75	0.19%	United States
4	Cigna Corporation 4 CI	USD 54.17 B	Sept. 30, 2024	USD 285.03	0.91%	United States
5	CVS Health Corporation 5 CVS	USD 52.38 B	Sept. 30, 2024	USD 51.57	0.10%	United States
6	Merck & Co., Inc. 6 MRK	USD 47.39 B	Sept. 30, 2024	USD 99.65	-1.32%	United States
7	AbbVie Inc. 7 ABBV	USD 42.68 B	Sept. 30, 2024	USD 175.55	-0.67%	United States
8	Pfizer Inc. 8 PFE	USD 35.52 B	Sept. 29, 2024	USD 26.41	-1.46%	United States
9	Bristol-Myers Squibb Company 9 BMY	USD 33.40 B	Sept. 30, 2024	USD 55.74	0.69%	United States
10	Eli Lilly and Company 10 LLY	USD 33.33 B	Sept. 30, 2024	USD 744.91	-6.59%	United States
11	Abbott Laboratories 11 ABT	USD 22.55 B	Sept. 30, 2024	USD 113.02	-0.15%	United States
12	Gilead Sciences, Inc. 12 GILD	USD 22.07 B	Sept. 30, 2024	USD 91.00	1.18%	United States
13	Centene Corporation 13 CNC	USD 20.97 B	Sept. 30, 2024	USD 63.40	-0.47%	United States
14	Amgen Inc. 14 AMGN	USD 19.57 B	Sept. 30, 2024	USD 267.10	-1.14%	United States
15	Thermo Fisher Scientific Inc. 15 TMO	USD 17.39 B	Sept. 28, 2024	USD 556.99	0.27%	United States
16	McKesson Corporation 16 MCK	USD 12.82 B	Sept. 30, 2024	USD 593.73	1.48%	United States
17	Colgate-Palmolive Company 17 CL	USD 12.12 B	Sept. 30, 2024	USD 87.67	0.65%	United States
18	Danaher Corporation 18 DHR	USD 11.94 B	Sept. 27, 2024	USD 237.62	-0.94%	United States
19	Regeneron Pharmaceuticals, Inc. 19 REGN	USD 11.69 B	Sept. 30, 2024	USD 690.87	-3.63%	United States
20	Boston Scientific Corporation 20 BSX	USD 10.71 B	Sept. 30, 2024	USD 95.65	1.10%	United States
21	Vertex Pharmaceuticals Incorporated 21 VRTX	USD 9.14 B	Sept. 30, 2024	USD 411.66	-0.41%	United States
22	Becton, Dickinson and Company 22 BDX	USD 9.12 B	Sept. 30, 2024	USD 235.80	-0.17%	United States
23	Cencora 23 COR	USD 9.00 B	Sept. 30, 2024	USD 240.05	1.68%	United States
24	Oscar Health, Inc. 24 OSCR	USD 8.22 B	Sept. 30, 2024	USD 14.93	5.36%	United States
25	GE HealthCare Technologies Inc. 25 GEHC	USD 8.08 B	Sept. 30, 2024	USD 84.13	-1.40%	United States
26	Cardinal Health, Inc. 26 CAH	USD 7.44 B	Sept. 30, 2024	USD 124.03	2.62%	United States
27	Biogen Inc. 27 BIIB	USD 6.75 B	Sept. 30, 2024	USD 143.06	-4.74%	United States
28	Zoetis Inc. 28 ZTS	USD 6.30 B	Sept. 30, 2024	USD 164.41	-1.15%	United States
29	Viatris Inc. 29 VTRS	USD 6.05 B	Sept. 30, 2024	USD 11.72	-0.68%	United States
30	Baxter International Inc. 30 BAX	USD 5.28 B	Sept. 30, 2024	USD 30.62	0.39%	United States
31	Intuitive Surgical, Inc. 31 ISRG	USD 5.27 B	Sept. 30, 2024	USD 538.88	-0.16%	United States
32	Zimmer Biomet Holdings, Inc. 32 ZBH	USD 5.03 B	Sept. 30, 2024	USD 104.71	-0.74%	United States
33	Solventum Corporation 33 SOLV	USD 4.59 B	Sept. 30, 2024	USD 70.19	2.45%	United States
34	IQVIA Holdings Inc. 34 IQV	USD 4.58 B	Sept. 30, 2024	USD 197.96	-3.26%	United States
35	Edwards Lifesciences Corporation 35 EW	USD 4.57 B	Sept. 30, 2024	USD 71.04	-0.07%	United States
36	Tenet Healthcare Corporation 36 THC	USD 3.94 B	Sept. 30, 2024	USD 127.63	-1.27%	United States
37	Herbalife Nutrition Ltd. 37 HLF	USD 3.84 B	Sept. 30, 2024	USD 6.18	-4.33%	United States
38	DaVita Inc. 38 DVA	USD 3.78 B	Sept. 30, 2024	USD 162.00	3.15%	United States
39	Incyte Corporation 39 INCY	USD 3.77 B	Sept. 30, 2024	USD 71.93	-0.61%	United States
40	Henry Schein, Inc. 40 HSIC	USD 3.77 B	Sept. 28, 2024	USD 71.27	0.81%	United States
41	Organon & Co. 41 OGN	USD 3.73 B	Sept. 30, 2024	USD 15.81	0.96%	United States
42	Agilent Technologies, Inc. 42 A	USD 3.54 B	Oct. 31, 2024	USD 143.43	1.04%	United States
43	Laboratory Corporation of America Holdings 43 LH	USD 3.37 B	Sept. 30, 2024	USD 234.50	0.17%	United States
44	Moderna, Inc. 44 MRNA	USD 3.35 B	Sept. 30, 2024	USD 34.46	-1.96%	United States
45	Quest Diagnostics Incorporated 45 DGX	USD 3.08 B	Sept. 30, 2024	USD 152.98	-0.19%	United States
46	ResMed Inc. 46 RMD	USD 2.75 B	Sept. 30, 2024	USD 228.83	-0.62%	United States
47	United Therapeutics Corporation 47 UTHR	USD 2.45 B	Sept. 30, 2024	USD 364.70	0.50%	United States
48	DexCom, Inc. 48 DXCM	USD 2.44 B	Sept. 30, 2024	USD 79.17	-0.84%	United States
49	IDEXX Laboratories, Inc. 49 IDXX	USD 2.34 B	Sept. 30, 2024	USD 418.63	-0.94%	United States
50	Avantor, Inc. 50 AVTR	USD 2.29 B	Sept. 30, 2024	USD 21.72	-1.36%	United States

1 2 3 4 … 14

Frequently Asked Questions

Which Pharmaceuticals company in United States has the highest Gross Profit ?

The Pharmaceuticals company in United States with the highest Gross Profit is Humana Inc. (NYSE: HUM) at USD 101.65 B.
Which Pharmaceuticals company in United States has the lowest Gross Profit ?

The Pharmaceuticals company in United States with the lowest Gross Profit is Albemarle Corporation (NYSE: ALB) at USD -769.26 M.

What are the top 10 Pharmaceuticals companies in United States by Gross Profit ?

The top 10 Pharmaceuticals companies in United States by Gross Profit are Humana Inc., UnitedHealth Group Incorporated, Johnson & Johnson, Cigna Corporation, CVS Health Corporation, Merck & Co., Inc., AbbVie Inc., Pfizer Inc., Bristol-Myers Squibb Company and Eli Lilly and Company.
What are the bottom 10 Pharmaceuticals companies in United States by Gross Profit ?

The bottom 10 Pharmaceuticals companies in United States by Gross Profit are Albemarle Corporation, Revolution Medicines, Inc., PureTech Health plc, Cytokinetics, Incorporated, GRAIL, LLC, Immuneering Corporation, Allogene Therapeutics, Inc., Fate Therapeutics, Inc., Syndax Pharmaceuticals, Inc. and bluebird bio, Inc..